nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Fluticasone furoate—asthma	0.0468	0.0796	CbGbCtD
Sibutramine—CYP3A4—Budesonide—asthma	0.0417	0.0709	CbGbCtD
Sibutramine—CYP3A4—Ciclesonide—asthma	0.0381	0.0649	CbGbCtD
Sibutramine—CYP3A4—Indacaterol—asthma	0.0381	0.0649	CbGbCtD
Sibutramine—CYP3A4—Salbutamol—asthma	0.0355	0.0603	CbGbCtD
Sibutramine—CYP3A4—Flunisolide—asthma	0.0355	0.0603	CbGbCtD
Sibutramine—CYP3A4—Salmeterol—asthma	0.0355	0.0603	CbGbCtD
Sibutramine—CYP3A4—Ipratropium bromide—asthma	0.0316	0.0538	CbGbCtD
Sibutramine—CYP3A4—Zileuton—asthma	0.0316	0.0538	CbGbCtD
Sibutramine—CYP3A4—Fluticasone Propionate—asthma	0.0301	0.0513	CbGbCtD
Sibutramine—CYP3A4—Zafirlukast—asthma	0.0278	0.0473	CbGbCtD
Sibutramine—CYP3A4—Tiotropium—asthma	0.0239	0.0407	CbGbCtD
Sibutramine—CYP3A4—Aminophylline—asthma	0.0228	0.0389	CbGbCtD
Sibutramine—CYP3A4—Theophylline—asthma	0.0215	0.0365	CbGbCtD
Sibutramine—CYP3A4—Montelukast—asthma	0.0204	0.0346	CbGbCtD
Sibutramine—CYP3A4—Loratadine—asthma	0.0204	0.0346	CbGbCtD
Sibutramine—CYP3A4—Methylprednisolone—asthma	0.0186	0.0317	CbGbCtD
Sibutramine—CYP3A4—Triamcinolone—asthma	0.0141	0.024	CbGbCtD
Sibutramine—CYP3A4—Betamethasone—asthma	0.0121	0.0206	CbGbCtD
Sibutramine—CYP3A4—Prednisolone—asthma	0.0119	0.0203	CbGbCtD
Sibutramine—CYP3A4—Hydrocortisone—asthma	0.0113	0.0193	CbGbCtD
Sibutramine—CYP3A4—Prednisone—asthma	0.0113	0.0192	CbGbCtD
Sibutramine—CYP3A4—Dexamethasone—asthma	0.00704	0.012	CbGbCtD
Sibutramine—SLC6A4—Serotonin Transporter Activity—IL1R1—asthma	0.00123	0.0877	CbGpPWpGaD
Sibutramine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—asthma	0.000937	0.067	CbGpPWpGaD
Sibutramine—SLC6A4—Serotonin Transporter Activity—NOS1—asthma	0.000743	0.0531	CbGpPWpGaD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—asthma	0.000572	0.0409	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—IL1R1—asthma	0.000522	0.0373	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—IL1R1—asthma	0.000449	0.0321	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—IL1R1—asthma	0.000397	0.0284	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—NOS1—asthma	0.000316	0.0226	CbGpPWpGaD
Sibutramine—SLC6A4—Serotonin Transporter Activity—IL1B—asthma	0.000303	0.0217	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—NOS1—asthma	0.000272	0.0194	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—NOS1—asthma	0.000241	0.0172	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—asthma	0.000223	0.0159	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PRMT5—asthma	0.000199	0.0142	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—asthma	0.000197	0.0141	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—asthma	0.000193	0.0138	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—PRMT1—asthma	0.000178	0.0127	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—asthma	0.000165	0.0118	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC18A3—asthma	0.000146	0.0104	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHAT—asthma	0.00014	0.01	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MYB—asthma	0.000129	0.00925	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—IL1B—asthma	0.000129	0.00922	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TACR1—asthma	0.000125	0.00893	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SERPINA1—asthma	0.000124	0.00886	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PRF1—asthma	0.00012	0.00858	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—NQO1—asthma	0.000119	0.00848	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—UTS2—asthma	0.000114	0.00818	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC18A3—asthma	0.000112	0.008	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—IL1B—asthma	0.000111	0.00793	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—asthma	0.000111	0.00792	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL13—asthma	0.000111	0.00791	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SERPINA1—asthma	0.000106	0.00762	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TAC1—asthma	0.000102	0.00728	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC30A8—asthma	0.000101	0.00725	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—GATA3—asthma	9.98e-05	0.00714	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—IL1B—asthma	9.82e-05	0.00702	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—asthma	9.81e-05	0.00702	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TRPA1—asthma	9.8e-05	0.00701	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	9.78e-05	0.00699	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—asthma	9.67e-05	0.00692	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—NQO1—asthma	9.52e-05	0.00681	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—HNMT—asthma	9.47e-05	0.00678	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SERPINA1—asthma	9.43e-05	0.00675	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—asthma	9.35e-05	0.00669	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—asthma	9.08e-05	0.0065	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC30A8—asthma	8.97e-05	0.00642	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—ESR2—asthma	8.96e-05	0.00641	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHAT—asthma	8.75e-05	0.00626	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TRPA1—asthma	8.68e-05	0.00621	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—STAT3—asthma	8.67e-05	0.0062	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NPS—asthma	8.31e-05	0.00595	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NQO1—asthma	8.19e-05	0.00586	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TNF—asthma	8.04e-05	0.00575	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—asthma	8.03e-05	0.00575	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTP1—asthma	7.94e-05	0.00568	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—HMOX1—asthma	7.83e-05	0.0056	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—asthma	7.3e-05	0.00522	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—NQO1—asthma	7.25e-05	0.00519	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—asthma	7.25e-05	0.00519	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ALDH2—asthma	7.13e-05	0.0051	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—asthma	7.13e-05	0.0051	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—ALDH2—asthma	7.08e-05	0.00506	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—AGER—asthma	7.04e-05	0.00503	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—asthma	6.92e-05	0.00495	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—asthma	6.83e-05	0.00488	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—asthma	6.73e-05	0.00482	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHAT—asthma	6.7e-05	0.0048	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NTRK1—asthma	6.46e-05	0.00462	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—asthma	6.4e-05	0.00458	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—PDGFB—asthma	6.28e-05	0.00449	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—asthma	6.27e-05	0.00449	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—AGER—asthma	6.05e-05	0.00433	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—asthma	6.05e-05	0.00433	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—asthma	5.97e-05	0.00427	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—asthma	5.63e-05	0.00403	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	5.61e-05	0.00402	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—asthma	5.56e-05	0.00398	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ADCY2—asthma	5.52e-05	0.00395	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ALDH2—asthma	5.47e-05	0.00391	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—PDGFB—asthma	5.4e-05	0.00386	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—AGER—asthma	5.36e-05	0.00383	CbGpPWpGaD
Sibutramine—Malaise—Methylprednisolone—asthma	5.16e-05	0.000129	CcSEcCtD
Sibutramine—Vertigo—Triamcinolone—asthma	5.15e-05	0.000129	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC30A8—asthma	5.15e-05	0.00368	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP4A—asthma	5.15e-05	0.00368	CbGpPWpGaD
Sibutramine—Syncope—Triamcinolone—asthma	5.14e-05	0.000129	CcSEcCtD
Sibutramine—Vertigo—Methylprednisolone—asthma	5.14e-05	0.000129	CcSEcCtD
Sibutramine—Syncope—Methylprednisolone—asthma	5.13e-05	0.000129	CcSEcCtD
Sibutramine—Discomfort—Hydrocortisone—asthma	5.12e-05	0.000129	CcSEcCtD
Sibutramine—Nausea—Budesonide—asthma	5.1e-05	0.000128	CcSEcCtD
Sibutramine—Oedema—Prednisolone—asthma	5.09e-05	0.000128	CcSEcCtD
Sibutramine—Anaphylactic shock—Prednisolone—asthma	5.09e-05	0.000128	CcSEcCtD
Sibutramine—Loss of consciousness—Triamcinolone—asthma	5.04e-05	0.000126	CcSEcCtD
Sibutramine—Loss of consciousness—Methylprednisolone—asthma	5.03e-05	0.000126	CcSEcCtD
Sibutramine—Shock—Prednisolone—asthma	5e-05	0.000126	CcSEcCtD
Sibutramine—Cough—Triamcinolone—asthma	5e-05	0.000126	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—asthma	4.99e-05	0.00357	CbGpPWpGaD
Sibutramine—Oedema—Hydrocortisone—asthma	4.97e-05	0.000125	CcSEcCtD
Sibutramine—Anaphylactic shock—Hydrocortisone—asthma	4.97e-05	0.000125	CcSEcCtD
Sibutramine—Convulsion—Triamcinolone—asthma	4.96e-05	0.000125	CcSEcCtD
Sibutramine—Tachycardia—Prednisolone—asthma	4.96e-05	0.000125	CcSEcCtD
Sibutramine—Convulsion—Methylprednisolone—asthma	4.95e-05	0.000124	CcSEcCtD
Sibutramine—Hypertension—Triamcinolone—asthma	4.95e-05	0.000124	CcSEcCtD
Sibutramine—Hypertension—Methylprednisolone—asthma	4.94e-05	0.000124	CcSEcCtD
Sibutramine—Infection—Hydrocortisone—asthma	4.93e-05	0.000124	CcSEcCtD
Sibutramine—Hyperhidrosis—Prednisolone—asthma	4.92e-05	0.000123	CcSEcCtD
Sibutramine—Shock—Hydrocortisone—asthma	4.89e-05	0.000123	CcSEcCtD
Sibutramine—Myalgia—Triamcinolone—asthma	4.88e-05	0.000122	CcSEcCtD
Sibutramine—Myalgia—Methylprednisolone—asthma	4.87e-05	0.000122	CcSEcCtD
Sibutramine—Arthralgia—Methylprednisolone—asthma	4.87e-05	0.000122	CcSEcCtD
Sibutramine—Eye disorder—Prednisone—asthma	4.86e-05	0.000122	CcSEcCtD
Sibutramine—Anxiety—Methylprednisolone—asthma	4.85e-05	0.000122	CcSEcCtD
Sibutramine—Tachycardia—Hydrocortisone—asthma	4.85e-05	0.000122	CcSEcCtD
Sibutramine—Skin disorder—Hydrocortisone—asthma	4.82e-05	0.000121	CcSEcCtD
Sibutramine—Ill-defined disorder—Betamethasone—asthma	4.82e-05	0.000121	CcSEcCtD
Sibutramine—Ill-defined disorder—Dexamethasone—asthma	4.82e-05	0.000121	CcSEcCtD
Sibutramine—Discomfort—Triamcinolone—asthma	4.82e-05	0.000121	CcSEcCtD
Sibutramine—Discomfort—Methylprednisolone—asthma	4.81e-05	0.000121	CcSEcCtD
Sibutramine—Hyperhidrosis—Hydrocortisone—asthma	4.8e-05	0.000121	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—PDGFB—asthma	4.78e-05	0.00342	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6R—asthma	4.77e-05	0.00341	CbGpPWpGaD
Sibutramine—Dry mouth—Triamcinolone—asthma	4.77e-05	0.00012	CcSEcCtD
Sibutramine—Angioedema—Betamethasone—asthma	4.75e-05	0.000119	CcSEcCtD
Sibutramine—Angioedema—Dexamethasone—asthma	4.75e-05	0.000119	CcSEcCtD
Sibutramine—Anorexia—Hydrocortisone—asthma	4.73e-05	0.000119	CcSEcCtD
Sibutramine—Angiopathy—Prednisone—asthma	4.72e-05	0.000118	CcSEcCtD
Sibutramine—Confusional state—Methylprednisolone—asthma	4.71e-05	0.000118	CcSEcCtD
Sibutramine—Immune system disorder—Prednisone—asthma	4.7e-05	0.000118	CcSEcCtD
Sibutramine—Malaise—Betamethasone—asthma	4.69e-05	0.000118	CcSEcCtD
Sibutramine—Malaise—Dexamethasone—asthma	4.69e-05	0.000118	CcSEcCtD
Sibutramine—Oedema—Triamcinolone—asthma	4.68e-05	0.000117	CcSEcCtD
Sibutramine—Anaphylactic shock—Triamcinolone—asthma	4.68e-05	0.000117	CcSEcCtD
Sibutramine—Vertigo—Betamethasone—asthma	4.67e-05	0.000117	CcSEcCtD
Sibutramine—Vertigo—Dexamethasone—asthma	4.67e-05	0.000117	CcSEcCtD
Sibutramine—Anaphylactic shock—Methylprednisolone—asthma	4.67e-05	0.000117	CcSEcCtD
Sibutramine—Syncope—Dexamethasone—asthma	4.66e-05	0.000117	CcSEcCtD
Sibutramine—Syncope—Betamethasone—asthma	4.66e-05	0.000117	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—LEP—asthma	4.65e-05	0.00333	CbGpPWpGaD
Sibutramine—Arrhythmia—Prednisone—asthma	4.65e-05	0.000117	CcSEcCtD
Sibutramine—Infection—Triamcinolone—asthma	4.65e-05	0.000117	CcSEcCtD
Sibutramine—Hypotension—Hydrocortisone—asthma	4.64e-05	0.000117	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	4.64e-05	0.00332	CbGpPWpGaD
Sibutramine—Infection—Methylprednisolone—asthma	4.64e-05	0.000116	CcSEcCtD
Sibutramine—Shock—Triamcinolone—asthma	4.6e-05	0.000116	CcSEcCtD
Sibutramine—Insomnia—Prednisolone—asthma	4.6e-05	0.000115	CcSEcCtD
Sibutramine—Alopecia—Prednisone—asthma	4.6e-05	0.000115	CcSEcCtD
Sibutramine—Shock—Methylprednisolone—asthma	4.59e-05	0.000115	CcSEcCtD
Sibutramine—Loss of consciousness—Betamethasone—asthma	4.57e-05	0.000115	CcSEcCtD
Sibutramine—Loss of consciousness—Dexamethasone—asthma	4.57e-05	0.000115	CcSEcCtD
Sibutramine—Paraesthesia—Prednisolone—asthma	4.57e-05	0.000115	CcSEcCtD
Sibutramine—Tachycardia—Triamcinolone—asthma	4.56e-05	0.000115	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP4A—asthma	4.56e-05	0.00326	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC30A8—asthma	4.56e-05	0.00326	CbGpPWpGaD
Sibutramine—Tachycardia—Methylprednisolone—asthma	4.55e-05	0.000114	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CAT—asthma	4.54e-05	0.00325	CbGpPWpGaD
Sibutramine—Skin disorder—Methylprednisolone—asthma	4.53e-05	0.000114	CcSEcCtD
Sibutramine—Malnutrition—Prednisone—asthma	4.53e-05	0.000114	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Hydrocortisone—asthma	4.53e-05	0.000114	CcSEcCtD
Sibutramine—Hyperhidrosis—Triamcinolone—asthma	4.52e-05	0.000114	CcSEcCtD
Sibutramine—Hyperhidrosis—Methylprednisolone—asthma	4.51e-05	0.000113	CcSEcCtD
Sibutramine—Convulsion—Dexamethasone—asthma	4.5e-05	0.000113	CcSEcCtD
Sibutramine—Convulsion—Betamethasone—asthma	4.5e-05	0.000113	CcSEcCtD
Sibutramine—Insomnia—Hydrocortisone—asthma	4.49e-05	0.000113	CcSEcCtD
Sibutramine—Hypertension—Betamethasone—asthma	4.49e-05	0.000113	CcSEcCtD
Sibutramine—Hypertension—Dexamethasone—asthma	4.49e-05	0.000113	CcSEcCtD
Sibutramine—Paraesthesia—Hydrocortisone—asthma	4.46e-05	0.000112	CcSEcCtD
Sibutramine—Myalgia—Betamethasone—asthma	4.43e-05	0.000111	CcSEcCtD
Sibutramine—Myalgia—Dexamethasone—asthma	4.43e-05	0.000111	CcSEcCtD
Sibutramine—Anxiety—Betamethasone—asthma	4.41e-05	0.000111	CcSEcCtD
Sibutramine—Anxiety—Dexamethasone—asthma	4.41e-05	0.000111	CcSEcCtD
Sibutramine—Discomfort—Betamethasone—asthma	4.37e-05	0.00011	CcSEcCtD
Sibutramine—Discomfort—Dexamethasone—asthma	4.37e-05	0.00011	CcSEcCtD
Sibutramine—Dyspepsia—Hydrocortisone—asthma	4.37e-05	0.00011	CcSEcCtD
Sibutramine—Hypotension—Methylprednisolone—asthma	4.36e-05	0.000109	CcSEcCtD
Sibutramine—Pain—Prednisolone—asthma	4.35e-05	0.000109	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—asthma	4.33e-05	0.0031	CbGpPWpGaD
Sibutramine—Decreased appetite—Hydrocortisone—asthma	4.32e-05	0.000108	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Hydrocortisone—asthma	4.29e-05	0.000108	CcSEcCtD
Sibutramine—Vision blurred—Prednisone—asthma	4.27e-05	0.000107	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Triamcinolone—asthma	4.26e-05	0.000107	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methylprednisolone—asthma	4.25e-05	0.000107	CcSEcCtD
Sibutramine—Pain—Hydrocortisone—asthma	4.25e-05	0.000107	CcSEcCtD
Sibutramine—Anaphylactic shock—Dexamethasone—asthma	4.24e-05	0.000107	CcSEcCtD
Sibutramine—Oedema—Betamethasone—asthma	4.24e-05	0.000107	CcSEcCtD
Sibutramine—Anaphylactic shock—Betamethasone—asthma	4.24e-05	0.000107	CcSEcCtD
Sibutramine—Oedema—Dexamethasone—asthma	4.24e-05	0.000107	CcSEcCtD
Sibutramine—Insomnia—Triamcinolone—asthma	4.23e-05	0.000106	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—ADCY2—asthma	4.23e-05	0.00302	CbGpPWpGaD
Sibutramine—Insomnia—Methylprednisolone—asthma	4.22e-05	0.000106	CcSEcCtD
Sibutramine—Infection—Dexamethasone—asthma	4.22e-05	0.000106	CcSEcCtD
Sibutramine—Infection—Betamethasone—asthma	4.22e-05	0.000106	CcSEcCtD
Sibutramine—Ill-defined disorder—Prednisone—asthma	4.2e-05	0.000105	CcSEcCtD
Sibutramine—Paraesthesia—Triamcinolone—asthma	4.2e-05	0.000105	CcSEcCtD
Sibutramine—Feeling abnormal—Prednisolone—asthma	4.19e-05	0.000105	CcSEcCtD
Sibutramine—Paraesthesia—Methylprednisolone—asthma	4.19e-05	0.000105	CcSEcCtD
Sibutramine—Anaemia—Prednisone—asthma	4.19e-05	0.000105	CcSEcCtD
Sibutramine—Shock—Betamethasone—asthma	4.17e-05	0.000105	CcSEcCtD
Sibutramine—Shock—Dexamethasone—asthma	4.17e-05	0.000105	CcSEcCtD
Sibutramine—Dyspnoea—Triamcinolone—asthma	4.17e-05	0.000105	CcSEcCtD
Sibutramine—Agitation—Prednisone—asthma	4.16e-05	0.000104	CcSEcCtD
Sibutramine—Thrombocytopenia—Betamethasone—asthma	4.15e-05	0.000104	CcSEcCtD
Sibutramine—Thrombocytopenia—Dexamethasone—asthma	4.15e-05	0.000104	CcSEcCtD
Sibutramine—Tachycardia—Betamethasone—asthma	4.14e-05	0.000104	CcSEcCtD
Sibutramine—Tachycardia—Dexamethasone—asthma	4.14e-05	0.000104	CcSEcCtD
Sibutramine—Angioedema—Prednisone—asthma	4.14e-05	0.000104	CcSEcCtD
Sibutramine—Dyspepsia—Triamcinolone—asthma	4.12e-05	0.000103	CcSEcCtD
Sibutramine—Dyspepsia—Methylprednisolone—asthma	4.11e-05	0.000103	CcSEcCtD
Sibutramine—Hyperhidrosis—Dexamethasone—asthma	4.1e-05	0.000103	CcSEcCtD
Sibutramine—Hyperhidrosis—Betamethasone—asthma	4.1e-05	0.000103	CcSEcCtD
Sibutramine—Feeling abnormal—Hydrocortisone—asthma	4.09e-05	0.000103	CcSEcCtD
Sibutramine—Malaise—Prednisone—asthma	4.08e-05	0.000103	CcSEcCtD
Sibutramine—Vertigo—Prednisone—asthma	4.07e-05	0.000102	CcSEcCtD
Sibutramine—Gastrointestinal pain—Hydrocortisone—asthma	4.06e-05	0.000102	CcSEcCtD
Sibutramine—Syncope—Prednisone—asthma	4.06e-05	0.000102	CcSEcCtD
Sibutramine—Anorexia—Dexamethasone—asthma	4.04e-05	0.000102	CcSEcCtD
Sibutramine—Anorexia—Betamethasone—asthma	4.04e-05	0.000102	CcSEcCtD
Sibutramine—Urticaria—Prednisolone—asthma	4.04e-05	0.000101	CcSEcCtD
Sibutramine—Pain—Triamcinolone—asthma	4e-05	0.0001	CcSEcCtD
Sibutramine—Loss of consciousness—Prednisone—asthma	3.98e-05	9.99e-05	CcSEcCtD
Sibutramine—Hypotension—Betamethasone—asthma	3.97e-05	9.96e-05	CcSEcCtD
Sibutramine—Hypotension—Dexamethasone—asthma	3.97e-05	9.96e-05	CcSEcCtD
Sibutramine—Urticaria—Hydrocortisone—asthma	3.95e-05	9.91e-05	CcSEcCtD
Sibutramine—Abdominal pain—Hydrocortisone—asthma	3.93e-05	9.86e-05	CcSEcCtD
Sibutramine—Body temperature increased—Hydrocortisone—asthma	3.93e-05	9.86e-05	CcSEcCtD
Sibutramine—Convulsion—Prednisone—asthma	3.92e-05	9.85e-05	CcSEcCtD
Sibutramine—Hypertension—Prednisone—asthma	3.91e-05	9.82e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Betamethasone—asthma	3.87e-05	9.71e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Dexamethasone—asthma	3.87e-05	9.71e-05	CcSEcCtD
Sibutramine—Myalgia—Prednisone—asthma	3.86e-05	9.68e-05	CcSEcCtD
Sibutramine—Arthralgia—Prednisone—asthma	3.86e-05	9.68e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Triamcinolone—asthma	3.85e-05	9.68e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Methylprednisolone—asthma	3.85e-05	9.66e-05	CcSEcCtD
Sibutramine—Anxiety—Prednisone—asthma	3.84e-05	9.65e-05	CcSEcCtD
Sibutramine—Insomnia—Dexamethasone—asthma	3.84e-05	9.64e-05	CcSEcCtD
Sibutramine—Insomnia—Betamethasone—asthma	3.84e-05	9.64e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methylprednisolone—asthma	3.82e-05	9.58e-05	CcSEcCtD
Sibutramine—Paraesthesia—Dexamethasone—asthma	3.81e-05	9.57e-05	CcSEcCtD
Sibutramine—Paraesthesia—Betamethasone—asthma	3.81e-05	9.57e-05	CcSEcCtD
Sibutramine—Discomfort—Prednisone—asthma	3.81e-05	9.56e-05	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—asthma	3.78e-05	0.00271	CbGpPWpGaD
Sibutramine—Hypersensitivity—Prednisolone—asthma	3.75e-05	9.41e-05	CcSEcCtD
Sibutramine—Dyspepsia—Dexamethasone—asthma	3.74e-05	9.38e-05	CcSEcCtD
Sibutramine—Dyspepsia—Betamethasone—asthma	3.74e-05	9.38e-05	CcSEcCtD
Sibutramine—Urticaria—Triamcinolone—asthma	3.72e-05	9.33e-05	CcSEcCtD
Sibutramine—Urticaria—Methylprednisolone—asthma	3.71e-05	9.31e-05	CcSEcCtD
Sibutramine—Body temperature increased—Triamcinolone—asthma	3.7e-05	9.28e-05	CcSEcCtD
Sibutramine—Anaphylactic shock—Prednisone—asthma	3.7e-05	9.28e-05	CcSEcCtD
Sibutramine—Oedema—Prednisone—asthma	3.7e-05	9.28e-05	CcSEcCtD
Sibutramine—Abdominal pain—Methylprednisolone—asthma	3.69e-05	9.26e-05	CcSEcCtD
Sibutramine—Decreased appetite—Betamethasone—asthma	3.69e-05	9.26e-05	CcSEcCtD
Sibutramine—Decreased appetite—Dexamethasone—asthma	3.69e-05	9.26e-05	CcSEcCtD
Sibutramine—Infection—Prednisone—asthma	3.67e-05	9.22e-05	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Dexamethasone—asthma	3.66e-05	9.2e-05	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Betamethasone—asthma	3.66e-05	9.2e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Hydrocortisone—asthma	3.66e-05	9.19e-05	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—SERPINE1—asthma	3.65e-05	0.00261	CbGpPWpGaD
Sibutramine—Shock—Prednisone—asthma	3.64e-05	9.13e-05	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—asthma	3.63e-05	0.0026	CbGpPWpGaD
Sibutramine—Pain—Dexamethasone—asthma	3.63e-05	9.11e-05	CcSEcCtD
Sibutramine—Pain—Betamethasone—asthma	3.63e-05	9.11e-05	CcSEcCtD
Sibutramine—Tachycardia—Prednisone—asthma	3.61e-05	9.06e-05	CcSEcCtD
Sibutramine—Skin disorder—Prednisone—asthma	3.59e-05	9.01e-05	CcSEcCtD
Sibutramine—Hyperhidrosis—Prednisone—asthma	3.57e-05	8.97e-05	CcSEcCtD
Sibutramine—Asthenia—Hydrocortisone—asthma	3.56e-05	8.95e-05	CcSEcCtD
Sibutramine—Anorexia—Prednisone—asthma	3.52e-05	8.85e-05	CcSEcCtD
Sibutramine—Pruritus—Hydrocortisone—asthma	3.51e-05	8.82e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Dexamethasone—asthma	3.5e-05	8.78e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Betamethasone—asthma	3.5e-05	8.78e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Betamethasone—asthma	3.47e-05	8.71e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Dexamethasone—asthma	3.47e-05	8.71e-05	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CARM1—asthma	3.46e-05	0.00247	CbGpPWpGaD
Sibutramine—Hypersensitivity—Triamcinolone—asthma	3.45e-05	8.65e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Methylprednisolone—asthma	3.44e-05	8.63e-05	CcSEcCtD
Sibutramine—Diarrhoea—Hydrocortisone—asthma	3.4e-05	8.53e-05	CcSEcCtD
Sibutramine—Urticaria—Betamethasone—asthma	3.37e-05	8.46e-05	CcSEcCtD
Sibutramine—Urticaria—Dexamethasone—asthma	3.37e-05	8.46e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Prednisone—asthma	3.37e-05	8.45e-05	CcSEcCtD
Sibutramine—Dizziness—Prednisolone—asthma	3.36e-05	8.44e-05	CcSEcCtD
Sibutramine—Asthenia—Triamcinolone—asthma	3.36e-05	8.43e-05	CcSEcCtD
Sibutramine—Abdominal pain—Betamethasone—asthma	3.35e-05	8.42e-05	CcSEcCtD
Sibutramine—Body temperature increased—Betamethasone—asthma	3.35e-05	8.42e-05	CcSEcCtD
Sibutramine—Abdominal pain—Dexamethasone—asthma	3.35e-05	8.42e-05	CcSEcCtD
Sibutramine—Body temperature increased—Dexamethasone—asthma	3.35e-05	8.42e-05	CcSEcCtD
Sibutramine—Asthenia—Methylprednisolone—asthma	3.35e-05	8.41e-05	CcSEcCtD
Sibutramine—Insomnia—Prednisone—asthma	3.34e-05	8.39e-05	CcSEcCtD
Sibutramine—Paraesthesia—Prednisone—asthma	3.32e-05	8.33e-05	CcSEcCtD
Sibutramine—Pruritus—Triamcinolone—asthma	3.31e-05	8.31e-05	CcSEcCtD
Sibutramine—Pruritus—Methylprednisolone—asthma	3.3e-05	8.29e-05	CcSEcCtD
Sibutramine—Dizziness—Hydrocortisone—asthma	3.28e-05	8.25e-05	CcSEcCtD
Sibutramine—Dyspepsia—Prednisone—asthma	3.25e-05	8.17e-05	CcSEcCtD
Sibutramine—Decreased appetite—Prednisone—asthma	3.21e-05	8.07e-05	CcSEcCtD
Sibutramine—Rash—Prednisolone—asthma	3.21e-05	8.05e-05	CcSEcCtD
Sibutramine—Dermatitis—Prednisolone—asthma	3.2e-05	8.04e-05	CcSEcCtD
Sibutramine—Diarrhoea—Methylprednisolone—asthma	3.19e-05	8.02e-05	CcSEcCtD
Sibutramine—Headache—Prednisolone—asthma	3.19e-05	8e-05	CcSEcCtD
Sibutramine—Constipation—Prednisone—asthma	3.16e-05	7.94e-05	CcSEcCtD
Sibutramine—Vomiting—Hydrocortisone—asthma	3.16e-05	7.93e-05	CcSEcCtD
Sibutramine—Rash—Hydrocortisone—asthma	3.13e-05	7.86e-05	CcSEcCtD
Sibutramine—Dermatitis—Hydrocortisone—asthma	3.13e-05	7.86e-05	CcSEcCtD
Sibutramine—Headache—Hydrocortisone—asthma	3.11e-05	7.81e-05	CcSEcCtD
Sibutramine—Dizziness—Triamcinolone—asthma	3.09e-05	7.77e-05	CcSEcCtD
Sibutramine—Dizziness—Methylprednisolone—asthma	3.09e-05	7.75e-05	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—asthma	3.07e-05	0.0022	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CARM1—asthma	3.06e-05	0.00219	CbGpPWpGaD
Sibutramine—Feeling abnormal—Prednisone—asthma	3.05e-05	7.65e-05	CcSEcCtD
Sibutramine—Asthenia—Dexamethasone—asthma	3.04e-05	7.64e-05	CcSEcCtD
Sibutramine—Asthenia—Betamethasone—asthma	3.04e-05	7.64e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Prednisone—asthma	3.02e-05	7.59e-05	CcSEcCtD
Sibutramine—Nausea—Prednisolone—asthma	3.02e-05	7.59e-05	CcSEcCtD
Sibutramine—Pruritus—Betamethasone—asthma	3e-05	7.54e-05	CcSEcCtD
Sibutramine—Pruritus—Dexamethasone—asthma	3e-05	7.54e-05	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—asthma	2.97e-05	0.00213	CbGpPWpGaD
Sibutramine—Vomiting—Triamcinolone—asthma	2.97e-05	7.47e-05	CcSEcCtD
Sibutramine—Vomiting—Methylprednisolone—asthma	2.97e-05	7.45e-05	CcSEcCtD
Sibutramine—Nausea—Hydrocortisone—asthma	2.95e-05	7.41e-05	CcSEcCtD
Sibutramine—Rash—Triamcinolone—asthma	2.95e-05	7.4e-05	CcSEcCtD
Sibutramine—Dermatitis—Triamcinolone—asthma	2.95e-05	7.4e-05	CcSEcCtD
Sibutramine—Rash—Methylprednisolone—asthma	2.94e-05	7.39e-05	CcSEcCtD
Sibutramine—Dermatitis—Methylprednisolone—asthma	2.94e-05	7.38e-05	CcSEcCtD
Sibutramine—Urticaria—Prednisone—asthma	2.94e-05	7.37e-05	CcSEcCtD
Sibutramine—Headache—Triamcinolone—asthma	2.93e-05	7.36e-05	CcSEcCtD
Sibutramine—Headache—Methylprednisolone—asthma	2.92e-05	7.34e-05	CcSEcCtD
Sibutramine—Abdominal pain—Prednisone—asthma	2.92e-05	7.34e-05	CcSEcCtD
Sibutramine—Body temperature increased—Prednisone—asthma	2.92e-05	7.34e-05	CcSEcCtD
Sibutramine—Diarrhoea—Betamethasone—asthma	2.9e-05	7.29e-05	CcSEcCtD
Sibutramine—Diarrhoea—Dexamethasone—asthma	2.9e-05	7.29e-05	CcSEcCtD
Sibutramine—Dizziness—Dexamethasone—asthma	2.81e-05	7.05e-05	CcSEcCtD
Sibutramine—Dizziness—Betamethasone—asthma	2.81e-05	7.05e-05	CcSEcCtD
Sibutramine—Nausea—Triamcinolone—asthma	2.78e-05	6.98e-05	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PTEN—asthma	2.78e-05	0.00199	CbGpPWpGaD
Sibutramine—Nausea—Methylprednisolone—asthma	2.77e-05	6.96e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Prednisone—asthma	2.72e-05	6.84e-05	CcSEcCtD
Sibutramine—Vomiting—Betamethasone—asthma	2.7e-05	6.77e-05	CcSEcCtD
Sibutramine—Vomiting—Dexamethasone—asthma	2.7e-05	6.77e-05	CcSEcCtD
Sibutramine—Rash—Dexamethasone—asthma	2.68e-05	6.72e-05	CcSEcCtD
Sibutramine—Rash—Betamethasone—asthma	2.68e-05	6.72e-05	CcSEcCtD
Sibutramine—Dermatitis—Betamethasone—asthma	2.67e-05	6.71e-05	CcSEcCtD
Sibutramine—Dermatitis—Dexamethasone—asthma	2.67e-05	6.71e-05	CcSEcCtD
Sibutramine—Headache—Betamethasone—asthma	2.66e-05	6.68e-05	CcSEcCtD
Sibutramine—Headache—Dexamethasone—asthma	2.66e-05	6.68e-05	CcSEcCtD
Sibutramine—Asthenia—Prednisone—asthma	2.65e-05	6.66e-05	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—asthma	2.63e-05	0.00188	CbGpPWpGaD
Sibutramine—Pruritus—Prednisone—asthma	2.61e-05	6.57e-05	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ADCY2—asthma	2.57e-05	0.00184	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—asthma	2.56e-05	0.00183	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—asthma	2.55e-05	0.00182	CbGpPWpGaD
Sibutramine—Diarrhoea—Prednisone—asthma	2.53e-05	6.35e-05	CcSEcCtD
Sibutramine—Nausea—Dexamethasone—asthma	2.52e-05	6.33e-05	CcSEcCtD
Sibutramine—Nausea—Betamethasone—asthma	2.52e-05	6.33e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—ALDH2—asthma	2.46e-05	0.00176	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.45e-05	0.00175	CbGpPWpGaD
Sibutramine—Dizziness—Prednisone—asthma	2.44e-05	6.14e-05	CcSEcCtD
Sibutramine—Vomiting—Prednisone—asthma	2.35e-05	5.9e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—asthma	2.34e-05	0.00168	CbGpPWpGaD
Sibutramine—Rash—Prednisone—asthma	2.33e-05	5.85e-05	CcSEcCtD
Sibutramine—Dermatitis—Prednisone—asthma	2.33e-05	5.85e-05	CcSEcCtD
Sibutramine—Headache—Prednisone—asthma	2.32e-05	5.81e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ADCY2—asthma	2.27e-05	0.00163	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—asthma	2.27e-05	0.00162	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—asthma	2.26e-05	0.00161	CbGpPWpGaD
Sibutramine—Nausea—Prednisone—asthma	2.2e-05	5.51e-05	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—asthma	2.16e-05	0.00154	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—asthma	2.13e-05	0.00152	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.99e-05	0.00142	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—asthma	1.91e-05	0.00137	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—asthma	1.74e-05	0.00124	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—asthma	1.62e-05	0.00116	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.6e-05	0.00115	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—asthma	1.49e-05	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.47e-05	0.00105	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—asthma	1.29e-05	0.000926	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—asthma	1.15e-05	0.000821	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—asthma	1.06e-05	0.000755	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LTC4S—asthma	9.95e-06	0.000712	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LTA4H—asthma	8.63e-06	0.000617	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ARG1—asthma	7.54e-06	0.00054	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH7A1—asthma	6.82e-06	0.000488	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ARG2—asthma	6.54e-06	0.000468	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALOX5AP—asthma	5.42e-06	0.000388	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALOX15—asthma	5.42e-06	0.000388	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CHAT—asthma	5.17e-06	0.00037	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALOX5—asthma	4.61e-06	0.00033	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CARM1—asthma	4.4e-06	0.000314	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DCN—asthma	4.33e-06	0.00031	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH2—asthma	4.21e-06	0.000301	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—asthma	4.01e-06	0.000287	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NQO1—asthma	3.33e-06	0.000238	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ADCY2—asthma	3.26e-06	0.000233	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—asthma	2.78e-06	0.000199	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—asthma	2.74e-06	0.000196	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ITPR1—asthma	2.73e-06	0.000196	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAT—asthma	2.7e-06	0.000193	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G4A—asthma	2.55e-06	0.000183	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—asthma	2.55e-06	0.000183	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPP2CA—asthma	2.35e-06	0.000168	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—asthma	1.8e-06	0.000129	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—asthma	1.65e-06	0.000118	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—asthma	1.57e-06	0.000113	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—asthma	1.44e-06	0.000103	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTEN—asthma	1.26e-06	8.98e-05	CbGpPWpGaD
